MOLECULAR CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2019-12-27 1531f65bc6m

您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表:
邮箱？

189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？

141 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2019-08-27 120cc505m10(暂无昵称)

我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表::
请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表:
请问一下endnote参考文献合适文件在哪可以找到？

157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？

155 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2020-02-07 tomsyu

这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48

134 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2023-12-04 ms2000001025016849 来自江苏省

MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2019-09-30 1460c76fm73暂无昵称

您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表:
我有，您还需要吗？

189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？

110 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2021-02-10 兰奇儿

一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……

103 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2020-02-07 tomsyu

直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表::
可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表:
可以看一下审稿状态？MolecularCancerResearch

小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch

152 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2021-12-23 ms3000002019295831

纯生信接收吗

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2019-11-01 14633d32m83(暂无昵称)

请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表:
我有，您还需要吗？

189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？

114 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=582249, encodeId=4be9582249c1, content=您好，能否方便发我一份endnote参考文献格式，1144522793@qq.com，谢谢您~189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, beContent=189PlKQ1410(暂无昵称) 2019-09-30 00:00:00 发表: 邮箱？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=1531f65bc6m, createdTime=Fri Dec 27 00:00:00 CST 2019, time=2019-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575422, encodeId=5fd05e542260, content=我有，您还需要吗？157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？157****1645暂无昵称 2019-06-18 00:00:00 发表: 请问一下endnote参考文献合适文件在哪可以找到？, beContent=157****1645暂无昵称 2019-06-18 发表:: 请问一下endnote参考文献合适文件在哪可以找到？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584359, encodeId=f151584359f6, content=这是第一次审稿时候的状态Revision Received 2019-11-11 04:16:44 Waiting for Revision 2019-09-13 11:16:37 Decision Sent to Author 2019-09-13 11:16:37 Under Review 2019-09-12 18:26:57 Decision Pending 2019-09-12 18:26:49 Under Review 2019-08-20 13:25:56 Under Editorial Consideration 2019-08-19 12:28:56 Initial QC 2019-08-17 04:17:49 Manuscript Submission 2019-08-16 09:34:48, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172850, encodeId=d85e21e2850bf, content=MOLECULAR CANCER RESEARCH 编辑考虑中要多久啊，一点动静都没, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=671b8848865, createdName=ms2000001025016849, createdTime=Mon Dec 04 13:10:37 CST 2023, time=2023-12-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=577162, encodeId=28895e716242, content=您好，我的学生也正好在投这个杂志，可否发一下endnote参考文献合适文件？感谢189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c5e5108395, createdName=1460c76fm73暂无昵称, createdTime=Mon Sep 30 00:00:00 CST 2019, time=2019-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924031, encodeId=c0a49240319b, content=一天之内经历了Under Editorial Consideration——Under Review——Decision Pending，而且后两个状态之间就差了10秒钟，请问哪位大神遇到过这种情况？是要凉了吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f7192315689, createdName=兰奇儿, createdTime=Wed Feb 10 10:14:36 CST 2021, time=2021-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584362, encodeId=c64658436238, content=直到二月六号才接受的，前后也得半年多吧！一个老牌杂志没那么好投，国人的文章相对比较少，先前我们有一篇Cancer research，所以才会认可我们这篇吧！小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch小悍马 2020-02-05 00:00:00 发表: 可以看一下审稿状态？MolecularCancerResearch, beContent=小悍马 2020-02-05 发表:: 可以看一下审稿状态？MolecularCancerResearch, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Feb 07 00:00:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083574, encodeId=e17610835e446, content=纯生信接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb25695200, createdName=ms3000002019295831, createdTime=Thu Dec 23 15:54:06 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579175, encodeId=59465e9175d0, content=请问可以发给我吗？邮箱919108892@qq.com 谢谢！189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, beContent=189PlKQ1410(暂无昵称) 2019-08-27 00:00:00 发表: 我有，您还需要吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68ed5120217, createdName=14633d32m83(暂无昵称), createdTime=Fri Nov 01 00:00:00 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584276, encodeId=7c845842e6c0, content=可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, beContent=tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/05/977312a6107dc1e8c6399ed50d519eb1.jpg, createdBy=be655274253, createdName=小悍马, createdTime=Wed Feb 05 00:00:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

2020-02-05 小悍马

可以看一下审稿状态？MolecularCancerResearchtomsyu 2020-01-22 00:00:00 发表:
文章今天已经顺利接收了

tomsyu 2020-01-22 00:00:00 发表: 文章今天已经顺利接收了

148 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务